EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nonspecific Inhibition of IL6 Family Cytokine Signalling by Soluble gp130

Anissa A Widjaja iD, Stuart A Cook

International Journal of Molecular Sciences · 23.01.2024 · 25 (3) · 1363

DOI: 10.3390/ijms25031363 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.01.2024. Verfasst von Anissa A Widjaja und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, 8 College Road, Singapore 169857, Singapore. Hauptthemen laut MEDLINE: Cytokines, Interleukin-6. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, National Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IL6 is a proinflammatory cytokine that binds to membrane-bound IL6 receptor (IL6R) or soluble IL6R to signal via gp130 in cis or trans, respectively. We tested the hypothesis that sgp130Fc, which is believed to be a selective IL6 trans-signalling inhibitor, is in fact a non-specific inhibitor of gp130 signalling. In human cancer and primary cells, sgp130Fc inhibited IL6, IL11, OSM and CT1 cis-signalling. The IC50 values of sgp130Fc for IL6 and OSM cis-signalling were markedly (20- to 200-fold) lower than the concentrations of sgp130Fc used in mouse studies and clinical trials. sgp130 inhibited IL6 and OSM signalling in the presence of an ADAM10/17 inhibitor and the absence of soluble IL6R or OSMR, with effects that were indistinguishable from those of a gp130 neutralising antibody. These data show that sgp130Fc does not exclusively block IL6 trans-signalling and reveal instead that broad inhibition of gp130 signalling likely underlies its therapeutic effects. This proposes global or modular inhibition of gp130 as a therapeutic approach for treating human disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytokinesInterleukin-6MiceHumansAnimalsCytokine Receptor gp130Signal TransductionReceptors, Interleukin-6

Stichwörter der Autor:innen

IL11IL6OSMOlamkiceptSTAT3cis-signalinggp130sgp130Fctrans-signaling

Substanzen

CytokinesCytokine Receptor gp130Interleukin-6Receptors, Interleukin-6

Autor:innen und Institutionen

  • Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, 8 College Road, Singapore 169857, Singapore.
  • National Heart Centre Singapore, National Heart Research Institute Singapore, Singapore 169609, Singapore.
  • MRC-London Institute of Medical Sciences, Hammersmith Hospital Campus, London W6 8RF, UK.

ORCID-Profile: Anissa A Widjaja

Förderung

  • Medical Research Council
  • National Medical Research Council

Zitieren

APA

Widjaja, A. A., & Cook, S. A. (2024). Nonspecific Inhibition of IL6 Family Cytokine Signalling by Soluble gp130. International Journal of Molecular Sciences, 25(3), 1363. https://doi.org/10.3390/ijms25031363

Vancouver

Widjaja AA, Cook SA. Nonspecific Inhibition of IL6 Family Cytokine Signalling by Soluble gp130. International Journal of Molecular Sciences. 2024;25(3):1363. doi:10.3390/ijms25031363

BibTeX
@article{Widjaja2024,
  author = {Widjaja, Anissa A and Cook, Stuart A},
  title = {Nonspecific Inhibition of IL6 Family Cytokine Signalling by Soluble gp130},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {3},
  pages = {1363},
  doi = {10.3390/ijms25031363}
}
Kostenlos starten →